ArticlePDF Available

Abstract and Figures

The current pandemic is caused by a novel coronavirus (CoV) called SARS-CoV-2 (species Severe acute respiratory syndrome-related coronavirus, subgenus Sarbecovirus, genus Betacoronavirus, family Coronaviridae). In Italy, up to the 2nd of April 2020, overall 139,422 confirmed cases and 17,669 deaths have been notified, while 26,491 people have recovered. Besides the overloading of hospitals, another issue to face was the capacity to perform thousands of tests per day. In this perspective, to support the National Health Care System and to minimize the impact of this rapidly spreading virus, the Italian Ministry of Health involved the Istituti Zooprofilattici Sperimentali (IZSs), Veterinary Public Health Institutes, in the diagnosis of SARS-CoV-2 by testing human samples. The Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise is currently testing more than 600 samples per day and performing whole genome sequencing from positive samples. Sequence analysis of these samples suggested that different viral variants may be circulating in Italy, and so in Abruzzo region. CoVs, and related diseases, are well known to veterinarians since decades. The experience that veterinarians operating within the Public Health system gained in the control and characterization of previous health issues of livestock and poultry including avian flu, bluetongue, foot and mouth disease, responsible for huge economic losses, is certainly of great help to minimize the impact of this global crisis.
Content may be subject to copyright.
Contents lists available at ScienceDirect
One Health
journal homepage: www.elsevier.com/locate/onehlt
AOne-Healthapproach for diagnosis and molecular characterization of
SARS-CoV-2 in Italy
Alessio Lorusso
a,
, Paolo Calistri
a
, Maria Teresa Mercante
a
, Federica Monaco
a
, Ottavio Portanti
a
,
Maurilia Marcacci
a
, Cesare Cammà
a
, Antonio Rinaldi
a
, Iolanda Mangone
a
, Adriano Di Pasquale
a
,
Marino Iommarini
b
, Maria Mattucci
c
, Paolo Fazii
d
, Pierluigi Tarquini
e
, Rinalda Mariani
f
,
Alessandro Grimaldi
g
, Daniela Morelli
a
, Giacomo Migliorati
a
, Giovanni Savini
a
, Silvio Borrello
h
,
Nicola D'Alterio
a
a
Istituto Zooprolattico Sperimentale dell'Abruzzo e Molise G. Caporale, Teramo, Italy
b
Ospedale San Liberatore Presidio COVID-19 Atri, Teramo, Italy
c
Direzione Sanitaria ASL, Teramo, Italy
d
Reparto di Microbiologia e Virologia clinica, Ospedale Civile Spirito Santo, Pescara, Italy
e
UOSD Malattie Infettive Ospedale G. Mazzini, Teramo, Italy
f
UOC Malattie Infettive Ospedale SS Filippo e Nicola, Avezzano (L' Aquila), Italy
g
UOC Malattie Infettive Ospedale S. Salvatore, L'Aquila, Italy
h
Direzione Generale della Sanita' Animale e dei Farmaci Veterinari, Ministero della Salute, Roma, Italy
ARTICLE INFO
Keywords:
SARS-CoV-2
COVID-19
Molecular characterization
Next generation sequencing
Mutations
Variants
One health
Veterinarians
ABSTRACT
The current pandemic is caused by a novel coronavirus (CoV) called SARS-CoV-2 (species Severe acute respiratory
syndrome-related coronavirus, subgenus Sarbecovirus, genus Betacoronavirus, family Coronaviridae). In Italy, up to
the 2nd of April 2020, overall 139,422 conrmed cases and 17,669 deaths have been notied, while 26,491
people have recovered. Besides the overloading of hospitals, another issue to face was the capacity to perform
thousands of tests per day. In this perspective, to support the National Health Care System and to minimize the
impact of this rapidly spreading virus, the Italian Ministry of Health involved the Istituti Zooprolattici
Sperimentali (IZSs), Veterinary Public Health Institutes, in the diagnosis of SARS-CoV-2 by testing human
samples. The Istituto Zooprolattico Sperimentale dell'Abruzzo e del Molise is currently testing more than 600
samples per day and performing whole genome sequencing from positive samples. Sequence analysis of these
samples suggested that dierent viral variants may be circulating in Italy, and so in Abruzzo region. CoVs, and
related diseases, are well known to veterinarians since decades. The experience that veterinarians operating
within the Public Health system gained in the control and characterization of previous health issues of livestock
and poultry including avian u, bluetongue, foot and mouth disease, responsible for huge economic losses, is
certainly of great help to minimize the impact of this global crisis.
1. Introduction
The current pandemic caused by a novel coronavirus (CoV) called
SARS-CoV-2 has been named by the World Health [1,2] Organization
(WHO) as COVID-19. Even if 80% of COVID-19 human cases are mild,
they can be still distressing and long-lasting. Most common symptoms
of the infection are fever, dry cough, and shortness of breath. About
20% of infected patients may develop severe cases, and a small per-
centage of them (5%) may become critically ill. Patients with severe
cases usually develop pneumonia or acute respiratory distress syndrome
(ARDS), a condition that may require mechanical ventilation and in-
tensive care unit treatment [3]. ARDS is often fatal [4]. The novel
epidemic, recognized as a public health emergency of international
concern on January 302,020, and acknowledged at a pandemic on
March 112,020, was initially recognized in December 2019 in Wuhan
City, Hubei Province, China, and continues to expand [5].
In Italy, up to the 8th of April 2020, overall 139,422 conrmed
cases and 17,669 deaths have been conrmed, while 26,491 people
have recovered (data source: National Department of Italian Civil
Protection, available at: http://arcg.is/C1unv). Italian policy makers
https://doi.org/10.1016/j.onehlt.2020.100135
Received 11 April 2020; Received in revised form 16 April 2020; Accepted 16 April 2020
Corresponding author at: Istituto Zooprolattico Sperimentale dell'Abruzzo e Molise G. Caporale, Campo Boario, 64100 Teramo, Italy.
E-mail address: a.lorusso@izs.it (A. Lorusso).
One Health 10 (2020) 100135
Available online 19 April 2020
2352-7714/ © 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/BY/4.0/).
T
continue to urge people to stay at home and observe social distancing.
Italy is experiencing more deaths than China, the country where the
infection originated, which now ocially reports 4,642 deaths. Since
the infection was rst identied in Codogno (Lombardy region) on
February 21st, in less than three weeks, COVID-19 overloaded the
National Health Care System (Servizio Sanitario Nazionale, SSN) in the
northern Italy. It turned the hard hit Lombardy region into a grim
glimpse of what countries may expect if they cannot slow down the
spread of the virus and atten the curveof new cases, which in turn
allows treatment of sick patients without overloading the capacity of
hospitals. Italy established draconian measures by restricting move-
ment and closing all stores except for pharmacies, groceries and other
social essential services. However, these measures did not come in time
to prevent the surge of cases that has deeply taxed the capacity even of
a well-regarded health care system.
SARS-CoV-2 belongs to the species Severe acute respiratory syndrome-
related CoVs (SARS-rCoV) within the subgenus Sarbecovirus, genus
Betacoronavirus together with SARS-CoV-1 strains from humans and
SARS-rCoVs from wild carnivores and horseshoe bats (genus
Rhinolophus)[2].
The virus harbors a linear single-stranded positive RNA genome of
nearly 30 kb. At the very 5-end of the genome is a leader sequence
which is the unique characteristic in CoV replication and plays critical
roles in the gene expression of CoV during its discontinuous sub-
genomic replication [6]. Downstream, the 5-most two-thirds of SARS-
CoV-2 genome comprises the replicase gene, which consists of two
overlapping open reading frames, ORF 1a and 1b translated to produce
two large polyproteins, pp1a and pp1b. Cleavage of the replicase
polyproteins is predicted to result in 16 end-products; nsp1nsp11 en-
coded in ORF1a and nsp1216 encoded in ORF1b [7]. Located down-
stream of ORF1b are four ORFs that code for structural proteins (spike
(S), envelope (E), membrane (M) and nucleocapsid (N) proteins) and
additional ORFs coding for accessory genes. As SARS-CoV-1, the S
(through the S1) protein mediates viral attachment to the specic cell
receptor angiotensin-converting enzyme type 2 (ACE2) [1] and fusion
between the envelope and plasma membrane. As for other CoVs, the S
protein is also the main inducer of virus-neutralising antibodies. The S
protein of SARS-CoV-2 has a functional polybasic (furin) cleavage site
at the S1S2 boundary through the insertion of 12 nucleotides, which
additionally lead to the predicted acquisition of three O-linked glycans
around the site [8]. Six residues of the receptor binding domain (RBD)
have been shown to be critical for binding to ACE2 receptors and for
determining the host range of SARS-CoV-1 like viruses. Based on
structural studies and biochemical experiments, SARS-CoV-2 seems to
have an RBD that binds with high anity to ACE2 also from ferrets and
cats [9].
The WHO denes a conrmed case as a person with laboratory
conrmation of COVID-19 infection irrespective of clinical signs and
symptoms.Indeed, another issue to face, in the eye of the storm, was
the capacity to perform thousands of tests per day. It is reasonable to
understand that reliable and fast diagnosis of COVID-19 infection is a
critical task to be performed. Without accurate collection of data and
metadata on COVID-19 spread we cannot possibly understand how the
pandemic is progressing. In this perspective, to support the SSN and to
minimize the impact of this rapidly spreading virus, the Italian Ministry
of Health (MoH) involved the Istituti Zooprolattici Sperimentali (IZSs)
in the diagnosis of SARS-CoV-2 by testing human samples. IZSs are
Public Health institutes which are coordinated by the MoH and act as
technical and operative support of the National Health Care System
with regard to animal health, healthiness and quality control for foods
of animal origin, breeding hygiene and correct relation between human
and animal settlements and the environment. They are ten and re-
present a network throughout the entire National territory.
2. Materials and methods
This paper aims at describing the rst three weeks of experience
gained by the Istituto Zooprolattico Sperimentale dell' Abruzzo e del
Molise (IZSAM) in the melieu of COVID-19 crisis in support of the di-
agnostic workow for SARS-CoV-2 of the Abruzzo region. The rst case
of COVID-19 in Abruzzo region was recorded on February 27
th
in a
male patient originating from Lombardy region who arrived in Abruzzo
for tourism several days before the movement restrictions implemented
rst in Lombardy region and in other provinces of northern Italy, and
then extended all over the Italian territory.
Samples tested for the presence of SARS-CoV-2 RNA are collected
from the respiratory tract of individuals which are either hospitalized,
or screened as for contact history with infected individuals or in the
framework of the screening programs for workers of the SSN. For the
vast majority, samples of hospitalized individuals originate from hos-
pitals located in dierent cities of Abruzzo region: Teramo (Ospedale
Civile Giuseppe Mazzini), Atri (Ospedale Civile S. Liberatore), Pescara
(Ospedale Civile Spirito Santo, Pescara), Avezzano (Ospedale Civile SS.
Nicola e Filippo), Sulmona (Ospedale SS Annunziata), Lanciano
(Ospedale Renzetti), L'Aquila (Ospedale Regionale S. Salvatore) and
Castel di Sangro (Ospedale Civile).
The workow for SARS-CoV-2 RNA detection is composed by two
steps. The rst includes virus inactivation (PrimeStore®MTM, in BSL3
biocontainment laboratory) starting from a total volume of 200 μlof
oropharyngeal (OF) swab transport medium (physiological solution) or
bronchoalveolar lavage (BAL) and nucleic acid purication
(MagMaxTM CORE) according to the manufacturer's instructions. The
second consists of RNA detection by the TaqMan
TM
2019-nCoV Assay
Kit v1 (Thermosher, qPCR) whose results are interpreted following the
manufacturer's instructions. Briey, this test targets three dierent
portions of SARS-CoV-2 genome located in the replicase, S and N pro-
tein encoding genes, respectively.
Laboratory activities are not limited to the molecular detection of
SARS-CoV-2 RNA. Selected positive samples showing low threshold
cycle (C
T
) values are regularly further processed by next generation
sequencing (NGS) in order to obtain the whole genome sequence of the
occurring strains. At the time this paper has been written, a total
number of 46 samples were processed by NGS. They were selected
within those collected from patients between the 16th and 23rd of
March 2020.
RNA from these infected samples was treated with TURBO DNase
(Thermo Fisher Scientic, Waltham, MA) at 37 °C for 20 min and then
puried by RNA Clean and Concentrator-5 Kit (Zymo Research). RNA
was used for the assessment of sequencing independent single primer
amplication protocol (SISPA) with some modication [10]. Briey,
cDNA was obtained by reverse-transcription (RT) using SuperScript®IV
Reverse Transcriptase (Thermo Fisher Scientic, Waltham, MA) and a
combination of two primers including the random-tagged primer
FR26RV-N 5-GCCGGAGCTCTGCAGATATCNNNNNN-3with a poly-A
tagged primer FR40RV-T 5-GCCGGAGCTCTGCAGATATCTTTTTTTTT
TTTTTTTTTTT-3[22]. The reaction was incubated at 23 °C for 10 min
and at 50 °C for 50 min. After an inactivation step at 80 °C for 10 min,
2.5 units of Klenow Fragment (35exo-) (New England Biolabs,
Ipswich, MA) was directly added to the reaction to perform the second
strand cDNA synthesis. The incubation was carried out at 37 °C for 1 h
and 75 °C for 10 min. Next, 5 μl of the ds cDNA was added to PCR
master mix containing 1× Q5 Reaction Buer, Q5 High-Fidelity DNA
Polymerase, dNTPs mix and the primer-tag FR20RV 5-GCCGGAGCTC
TGCAGATATC-3[11]. The incubation was performed with the fol-
lowing thermal conditions: 98 °C for 1 min, 40 cycles of 98 °C for 10 s,
65 °C for 30 s and 72 °C for 3 min and a nal extension step of 72 °C for
2 min. The PCR product was puried by ExpinTM PCR SV (GeneAll
Biotechnology CO., LTD Seoul, Korea) and then quantied using the
QuantiFluor One ds DNA System kit (Promega). Libraries were pre-
pared by using Nextera DNA Flex Library Prep (Illumina Inc., San
A. Lorusso, et al. One Health 10 (2020) 100135
2
Diego, CA) according to the manufacturer's protocol. Deep sequencing
was performed on the MiniSeq (Illumina Inc., San Diego, CA) by the
MiniSeq Mid Output Kit (300-cycles) and standard 150 bp paired-end
reads. Reads obtained were trimmed by trimmomatic [12] and mapped
on the host genome (GCF_000001405) using bowtie2 [13]; only un-
mapped reads were retained for downstream analysis. SARS-CoV-2
consensus sequence was obtained using samtools suite [14] after reads
was mapped to reference sequence (NC_045512, Wuhan-Hu-1) by
bowtie2.
3. Results
Starting from March 16
th
and up to April 8
th
around 8000 samples
were processed at IZSAM. In the rst week of testing, not more than
150200 samples per day were tested, but in the following days the
laboratory capacity was increased up to around 600 samples/day.
Overall, 839 out of 7994 samples tested positive by qPCR (Fig. 1).
Correlation between qPCR-negative/positive samples and age is
showed in Table 1 and Fig. 2.
Out of 46 samples sent for NGS, 45/46 sequences were suitable for
downstream analysis. Only one sequence was discarded as only few
reads were obtained. Out of 45 sequences, 16 were complete or almost
complete (horizontal coverage > 95,2%) and with high vertical
coverage. They were deposited in the GISAID database [15]; as listed in
Table 2. All obtained sequences in this study showed > 99% of nu-
cleotide (nt) identity with Wuhan-Hu-1 (NC_045512) SARS-CoV-2 re-
ference strain. However, all of them had single nucleotide poly-
morphisms (SNPs) with respect the reference Wuhan-Hu-1 sequence.
All sequences either partial or complete, show a rst common SNP
mutation in the leader sequence (241C > T) which co-evolved with
3037C > T, 14408C > T, and 23403A > G [16]. While 3037C > T
causes a synonymous mutations in nsp3 (F105F) 14408C > T and
23403A > G cause amino acid mutations in RNA primase (nsp 12,
P323L), and S protein (D614G), respectively. The four co-mutations are
prevalent in viral isolates from Europe. All sequences obtained in this
study, but one, had 27046C (T175 in the coded M protein); one se-
quence from Pescara, which was not deposited with GISAID, had the
mutation 27046C > T (T175M in the M protein). Moreover, 29/45 (12/
16 of those which have been deposited) sequences showed R203K and
G204R in the N protein as for the presence of mutations 28881G > A,
28882G > A, and 28883G > C in the nucleotide sequence. For 3/45 of
sequences, the obtained sequence reads did not cover that portion of
genome. According to GISAID (Genomic epidemiology of hCoV,
https://www.gisaid.org/epiu-applications/next-hcov-19-app/), these
mutations in the N protein rst appeared in a SARS-CoV-2 sequence
from northern Europe (hCoV-19/Netherlands/Berlicum_1363564/
2020, EPI_ISL_413565) originating from a sample collected on February
24
th
with a travel history to Italy Regarding Italian sequences, the same
mutations were also identied in one sequence recently released from
the Laboratory of Virology Lazzaro Spallanzani (Rome) and collected
on February 28
th
from a male patient aged 41 years. Interestingly, a
sequence obtained from a sample collected from the hospital of Atri
(TE7097), which was not deposited with GISAID as for suboptimal
horizontal coverage, did not show D614G in the S protein, typical of
European strains, thus retaining the D614 of early Chinese strains.
Unfortunately, we could not investigate for the presence of D614G co-
mutations and residues in position 203 and 204 of the N protein as for
Fig. 1. Temporal distribution of samples tested by results and percentage of positive samples.
Table 1
Age mean values of individuals tested positive and negative for SARS-CoV-2. (p-
Value < .0001, two tails Mann-Whitney Test).
Age (years)
Negative Positive
Mean 50.2 55.6
Median 49.6 56.9
Standard deviation 16.5 20.0
A. Lorusso, et al. One Health 10 (2020) 100135
3
the absence of sequence coverage in those portions of the genome. No
mutations were observed in critical residues of the S1 protein.
Genome analysis suggests that dierent viral SARS-CoV-2 variants
might be circulating in Italy and so in Abruzzo region.
Although the hallmark characterizing SARS-CoV-2 strains observed
in this study are mainly located in the N protein, there is no evidence of
geographical clustering in the Abruzzo region related to the two N
protein viral variants. Sequences showing R203K and G204R in the N
protein, according to GISAID, were evidenced primarily in northern
Europe, but also recently in dierent countries including, within the
others, USA, Spain, Greece, Vietnam and South America. As there is a
critical lack of SARS-CoV-2 sequences from northern Italy, speculations
upon the origin of the N protein viral variants can be made once a
clearer picture of the genomic characteristics of the viruses circulating
in Italy is available. In this regard, it would be important to obtain the
sequence information of the early SARS-CoV-2 strains detected in
Abruzzo and northern Italian regions to draw evidenced-based con-
clusions. The N protein of SARS-CoV-1 is responsible for the formation
of the helical nucleocapsid during virion assembly. The N protein may
cause an immune response and has potential value in vaccine
development [17]. Hence, these mutations shall be considered when
developing a vaccine using the N protein. Reasonably, the role of these
mutations needs to be investigated by proper biochemical and reverse
genetics experiments.
4. Discussion
Diagnosis of SARS-CoV-2 is currently performed in Italy and so in
Abruzzo region, in a One Health perspective, with the support of the
network of the IZSs. This decision arose by the combination of various
relevant factors. Firstly, the IZSs belong to the SSN, coordinated by the
MoH, and such condition facilitates the establishment of fruitful col-
laborations with the Public Health sectors, including the development
of common diagnostic and data exchange protocols. Secondly, each IZS
has the technical and scientic capacities to support the SSN to meet
the extraordinary surge in demand for diagnostic testing of human
samples for SARS-CoV-2. Lastly, IZSs have also experience in quality
assurance, biosafety, biosecurity, and high throughput testing for the
surveillance and control of infectious diseases in animals, some of
which, including the current SARS-CoV-2, are zoonotic. Moreover, they
0
50
100
150
200
250
300
Age (years)
Number of tested
Negave Posive
Fig. 2. Number of positive and negative samples by age (years) of patients.
Table 2
SARS-CoV-2 sequenced and deposited with GISAID. M, male; F, female. Age is expressed in years.
Strain GISAID acc.no Hospital Sex, Age N genotype Vertical coverage Horizontal coverage
hCoV-19/Italy/TE4836/2020 EPI_ISL_418260 Teramo M, 41 R203, G204 346 X 98,90%
hCoV-19/Italy/TE4959/2020 EPI_ISL_418259 Pescara M, 76 K203, R204 197 X 99,98%
hCoV-19/Italy/TE5056/2020 EPI_ISL_418257 Teramo F, 75 K203, R204 297 X 99,99%
hCoV-19/Italy/TE4880/2020 EPI_ISL_418256 Atri M, 80 K203, R204 1268 X 99,31%
hCoV-19/Italy/TE4925/2020 EPI_ISL_418255 Pescara F, 63 K203, R204 1751 X 99,70%
hCoV-19/Italy/TE4953/2020 EPI_ISL_418258 Pescara M, 87 K203, R204 2462 X 99,98%
hCoV-19/Italy/TE5052/2020 EPI_ISL_418261 Teramo F, 78 R203, G204 87 X 95,19%
hCoV-19/Italy/TE5166/2020 EPI_ISL_420563 Teramo M, 68 R203, G204 2501 X 100%
hCoV-19/Italy/TE5472/2020 EPI_ISL_420564 Castel di Sangro M, 54 R203, G204 1960 X 99,98%
hCoV-19/Italy/TE5476/2020 EPI_ISL_420565 Teramo M, 61 K203, R204 224 X 99,85%
hCoV-19/Italy/TE5512/2020 EPI_ISL_420566 L' Aquila M, 71 K203, R204 101 X 99,67%
hCoV-19/Italy/6193/2020 EPI_ISL_420568 Teramo M, 43 K203, R204 3721 X 99,87%
hCoV-19/Italy/TE6225/2020 EPI_ISL_420592 Teramo F, 29 K203, R204 126 X 98,85%
hCoV-19/Italy/TE5780/2020 EPI_ISL_420567 L'Aquila M, 64 K203, R204 447 X 99,86%
hCoV-19/Italy/TE6195/2020 EPI_ISL_420569 Teramo M, 86 K203, R204 2850 X 99,97%
hCoV-19/Italy/TE6222/2020 EPI_ISL_420583 Teramo M, 38 K203, R204 538 X 99,94%
A. Lorusso, et al. One Health 10 (2020) 100135
4
are also equipped with large infrastructure for genomic analysis and
storage of sequence data. These infrastructures are routinely used in
animal health and food security emergences and for diagnostic pur-
poses. In this regard, the analysis of the whole viral genome of SARS-
CoV-2 strains is a critical task. However, still scarce is genomic data
(and related metadata) available from SARS-CoV-2 strains circulating in
Italy and further eorts are necessarily warranted. Whole genome se-
quencing straight from infected biological samples may indeed provide
useful information to identify mutations during the virus adaptation to
humans, such as mutations in critical residues of the S protein or re-
sulting in the loss of accessory genes as already described for SARS-
CoV-1 [18]. An additional factor which may have inuenced the choice
of appointing IZSs to support the SSN's eort against COVID-19 was
related to the biological nature of the occurring agent. CoVs act as
primary actors within the so-called human/animal interface across
which a plethora of infectious pathogens has been observed to emerge,
spill over various species and eventually evolve, thus nding new
ecological niches and causing new epidemiological phenomena. Of
value, in the Italian context, is certainly the experience that veter-
inarians operating within the Public Health system gained in the control
and characterization of previous health issues of livestock and poultry
including avian u, bluetongue, foot and mouth disease, and BSE,
which were responsible for huge economic losses. This aptitude of being
ready to actionduring a health emergence certainly includes rapid
diagnosis, epidemiological investigations, molecular/antigenic char-
acterization, development of vaccines, and planning of surveillance
programs, a process that is pursued, together with saving patients' lives
in hospitals, by technicians and scientists around the globe for COVID-
19. We add to this the fact that veterinarians have known of CoVs and
related diseases for decades [5,19], thus, the One Health concept is
central and should again be sublimated and adopted to control critical
health emergencies, including that of antimicrobial resistance.
Therefore, the multidisciplinary involvement of dierent profes-
sionals operating within the SSN is crucial to properly and eectively
face the challenges posed by viruses like SARS-CoV-2. A holistic and
One Health approach is the sole solution for better understanding the
epidemiological aspect of this disease and possibly preventing the es-
tablishment of new transmission chains. Currently, the available
genome sequences so far clearly reveal that the most closely related
virus (96.2% of nt sequence identity) to SARS-CoV-2 is a strain from a
bat, Rhinolophus anis, identied as strain BatCoVRaTG13 from a
faecal sample in Yunnan province, China; and that the next closest
viruses are SARS-rCoVs identied from pangolins [23], however, the
exact origin of SARS-CoV-2 has yet to be demonstrated. In this per-
spective, veterinary virologists may surely support this important task
as well as those doomed to understand SARS-CoV-2 virulence factors
through the assessment of reverse genetics studies and animal models,
and to analyze the impact of the hyperinammation observed in
COVID-19 infected patients, characterized by a cytokine storm. This
latter evidence is not novel for veterinarians as it is observed in cats
infected with feline infectious peritonitis virus, a lethal pathotype of the
feline enteric coronavirus [20].
As for cats, recent evidences also demonstrated that they might get
infected from COVID-19 positive humans (https://www.nature.com/
articles/d41586-020-00984-8) or following experimental infection
[21], thus conrming the high anity of SARS-CoV-2 with feline ACE2.
Although the role of domestic animals in the epidemiology of SARS-
CoV-2 seems to be negligible, further studies are reasonably warranted.
Moreover, to plan future strategies for SARS-CoV-2 containment, it will
be essential to better understand the protective role of the various
classes of antibodies against the virus, as well as the prevalence of
serologically positive individuals in the human population when the
epidemic curve has shown a stable decrease. Also for these purposes,
the IZSs' laboratories will be useful for processing a large number of
serum samples and to support the Public Health Institutes in the ne-
cessary experimental studies.
Declaration of Competing Interest
Authors declare no conict of interest.
Acknowledgments
The authors deeply acknowledge all the health care workers in-
cluding doctors, nurses, technicians, medical sta, administrators, food
and cleaning service workers, pharmacists, and all members of the
COVID-19 diagnostic group at IZSAM. Mention of trade names or
commercial products in this article is solely for the purpose of providing
specic information and does not imply recommendation or endorse-
ment by the IZSAM. Funding were provided by the SSN.
References
[1] P. Zhou, X.L. Yang, X.G. Wang, B. Hu, L. Zhang, W. Zhang, H.R. Si, Y. Zhu, B. Li,
C.L. Huang, H.D. Chen, J. Chen, Y. Luo, H. Guo, R.D. Jiang, M.Q. Liu, Y. Chen,
X.R. Shen, X. Wang, X.S. Zheng, K. Zhao, Q.J. Chen, F. Deng, L.L. Liu, B. Yan,
F.X. Zhan, Y.Y. Wang, G.F. Xiao, Z.L. Shi, A pneumonia outbreak associated with a
new coronavirus of probable bat origin, Nature (2020), https://doi.org/10.1038/
s41586-020-2012-7.
[2] A.E. Gorbalenya, S.C. Baker, R.S. Baric, R.J. de Groot, C. Drosten, A.A. Gulyaeva,
B.L. Haagmans, C. Lauber, A.M. Leontovich, B.W. Neuman, D. Penzar, S. Perlman,
L.L.M. Poon, D.V. Samborskiy, I.A. Sidorov, I. Sola, J. Ziebuhr, The species Severe
acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming
it SARS-CoV-2, Nat. Microbiol. 4 (2020) 536544, https://doi.org/10.1038/
s41564-020-0695-z (Epub 2020 Mar 2).
[3] X. Yang, Y. Yu, J. Xu, H. Shu, J. Xia, H. Liu, et al., Clinical course and outcomes of
critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-cen-
tered, retrospective, observational study, Lancet Respir. Med. (2020), https://doi.
org/10.1016/S2213-2600(20)30079-5 Epub 2020/02/28.
[4] M.A. Matthay, R.L. Zemans, G.A. Zimmerman, et al., Acute respiratory distress
syndrome, Nat. Rev. Dis. Primers 5 (2019), https://doi.org/10.1038/s41572-019-
0069-0.
[5] A. Lorusso, P. Calistri, A. Petrini, G. Savini, N. Decaro, Novel coronavirus (SARS-
CoV-2) epidemic: a veterinary perspective, Vet. Ital. (2020), https://doi.org/10.
12834/VetIt.2173.11599.1.
[6] T. Li, Y. Zhang, L. Fu, C. Yu, X. Li, Y. Li, X. Zhang, Z. Rong, Y. Wang, H. Ning, et al.,
siRNA targeting the leader sequence of SARS-CoV inhibits virus replication, Gene
Ther. 12 (2005) 751761.
[7] J. Ziebuhr, E.J. Snijder, A.E. Gorbalenya, Virus-encoded proteinases and proteolytic
processing in the Nidovirales, J. Gen. Virol. 81 (2000) 853879.
[8] A.C. Walls, Y.J. Park, M.A. Tortorici, A. Wall, A.T. McGuire, D. Veesler, Structure,
function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell (2020),
https://doi.org/10.1016/j.cell.2020.02.058 pii: S00928674(20)302622.
[9] K.G. Andersen, A. Rambaut, W.I. Lipkin, et al., The proximal origin of SARS-CoV-2,
Nat. Med. (2020), https://doi.org/10.1038/s41591-020-0820-9.
[10] M. Marcacci, E. De Luca, G. Zaccaria, M. Di Tommaso, I. Mangone, G. Aste,
G. Savini, A. Boari, A. Lorusso, Genome characterization of feline morbillivirus from
Italy, J. Virol. Methods 234 (2016) 160163.
[11] T. Allander, M.T. Tammi, M. Eriksson, A. Bjerkner, A. Tiveljung-Lindell,
B. Andersson, Cloning of a human parvovirus by molecular screening of respiratory
tract samples, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1289112896.
[12] A.M. Bolger, M. Lohse, B. Usadel, Trimmomatic: a exible trimmer for illumina
sequence data, Bioinformatics 30 (2014) 21142120, https://doi.org/10.1093/
bioinformatics/btu170.
[13] B. Langmead, S. Salzberg, Fast gapped-read alignment with bowtie 2, Nat. Methods
9 (2012) 357359.
[14] H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth,
G. Abecasis, R. Durbin, 1000 Genome Project Data Processing Subgroup, The
Sequence alignment/map (SAM) format and SAMtools, Bioinformatics 25 (2009)
20782079.
[15] Y. Shu, J. McCauley, GISAID: Global initiative on sharing all inuenza data from
vision to reality, EuroSurveillance 22 (2017), https://doi.org/10.2807/1560-7917.
ES.2017.22.13.30494.
[16] C. Yin, Genotyping Coronavirus SARS-CoV-2: Methods and implications.
arXiv:2003.10965 [q-bio.GN], 2020.
[17] P. Zhao, J. Cao, L. Zhao, Z. Qin, J. Ke, W. Pan, H. Ren, J. Yu, Z. Qi, Immune re-
sponses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine,
Virology 331 (2005) 128135.
[18] J. Cui, F. Li, Z.L. Shi, Origin and evolution of pathogenic coronaviruses, Nat. Rev.
Microbiol. 17 (2019) 181192.
[19] N. Decaro, A. Lorusso, Novel human coronavirus (SARS-CoV-2): a lesson from an-
imal coronaviruses, Vet. Microbiol. (2020), https://doi.org/10.1016/j.vetmic.2020.
108693.
[20] N. Decaro, V. Martella, L.J. Saif, C. Buonavoglia, COVID-19 from veterinary med-
icine and one health perspectives: what animal coronaviruses have taught us, Res.
Vet. Sci. 131 (2020) 2123.
[21] J. Shi, Z. Wen, G. Zhong, H. Yang, C. Wang, R. Liu, X. He, L. Shuai, Z. Sun, Y. Zhao,
A. Lorusso, et al. One Health 10 (2020) 100135
5
L. Liang, P. Cui, J. Wang, X. Zhang, Y. Guan, H. Chen, Z. Bu, Susceptibility of ferrets,
cats, dogs, and other domesticated animals to SARS-coronavirus 2, Science (2020),
https://doi.org/10.1126/science.abb7015 In press.
[22] A. Djikeng, R. Halpin, R. Kuzmickas, J. Depasse, J. Feldblyum, N. Sengamalay,
C. Afonso, X. Zhang, N.G. Anderson, E. Ghedin, D.J. Spiro, Viral genome sequencing
by random priming methods, BMC Genomics 9 (5) (2008), https://doi.org/10.
1186/1471-2164-9-5.
[23] T.T. Lam, M.H. Shum, H.C. Zhu, Y.G. Tong, X.B. Ni, Y.S. Liao, W. Wei, Y.W. Cheung,
W.J. Li, L.F. Li, G.M. Leung, E.C. Holmes, Y.L. Hu, Y. Guan, Identifying SARS-CoV-2
related coronaviruses in Malayan pangolins, Nature (2020), https://doi.org/10.
1038/s41586-020-2169-0.
A. Lorusso, et al. One Health 10 (2020) 100135
6
... The robustness of branches was evaluated using ultrafast bootstrap approximation tests. The whole-genome sequence of EV-C105 strains was also recovered using the metagenomic approach, as previously described [8,9]. The IDseq pipeline was used to perform read quality control, alignment, and assembly to derive consensus EV-C105 whole-genome sequences by exploiting the metagenomic pipeline (reference genome: KM880100.1). ...
Article
Full-text available
In an epidemiologic investigation of Enterovirus (EV) infections in a Verona hospital, September 2022–September 2024, we detected EV-C105 in six pediatric patients with upper respiratory symptoms between March and May 2023. The primary objective was to describe the local incidence of EV cases. The secondary objective was to perform Sanger’s genomic characterization and the whole-genome sequencing (WGS) of EV-C105. The proportion of positive EV results was calculated based on routine molecular method testing. An available cohort of 114 underwent Sanger sequencing, and the six EV-C105 were characterized with WGS. Overall, 96% EV results were from the upper respiratory tract. The total proportion of positives in children was 83%. Out of the typed 114, 90% were Rhinoviruses and 9%, EVs. Notably, six pediatric cases were EV-C105, placing together in a unique cluster with 99% of nucleotides belonging to the European lineage with the highest Average Nucleotide Identity, including EV-C104, EV-C109, and EV-C118. Our data describes the first cluster indicating that EV-C105 incidence may be higher than previously estimated. However, a limitation for affirming this hypothesis is the lack of a more in-depth epidemiological investigation on a larger case series with the possibility of including data from coordinated laboratories.
... RNA was treated with TURBO DNase (Thermo Fisher Scientific, Waltham, MA) at 37 • C for 20 min and then purified by RNA Clean and Concentrator-5 Kit (Zymo Research). RNA was used for the assessment of sequencing independent single primer amplification protocol (SISPA) with some modifications reported by Lorusso [27]. Libraries were prepared by using Nextera DNA Flex Library Prep (Illumina Inc., San Diego, CA) according to the manufacturer's protocol. ...
Article
Full-text available
Introduction: Here we reported the virological, entomological and epidemiological characteristics of the large autochthonous outbreak of dengue (DENV) occurred in a small village of the Lombardy region (Northern Italy) during summer 2023. Methods: After the diagnosis of the first autochthonous case on August 18, 2023, public health measures, including epidemiological investigation and vector control measures, were carried out. A serological screening for DENV antibodies detection was offered to the population. In the case of positive DENV IgM, a second sample was collected to detect DENV RNA and verify seroconversion. Entomological and epidemiological investigations were also performed. A modeling analysis was conducted to estimate the dengue generation time, transmission potential, distance of transmission, and assess diagnostic delays. Results: Overall, 416 subjects participated to the screening program and 20 were identified as DENV-1 cases (15 confirmed and 5 probable). In addition, DENV-1 infection was diagnosed in 24 symptomatic subjects referred to the local Emergency Room Department for suggestive symptoms and 1 case was identified through blood donation screening. The average generation time was estimated to be 18.3 days (95 % CI: 13.1-23.5 days). R 0 was estimated at 1.31 (95 % CI: 0.76-1.98); 90 % of transmission occurred within 500m. Entomological investigations performed in 46 pools of mosquitoes revealed the presence of only one positive pool for DENV-1. Discussion: This report highlights the importance of synergic surveillance, including virological, entomological and public health measures to control the spread of arboviral infections.
... RNA was treated with TURBO DNase (Thermo Fisher Scientific, Waltham, MA) at 37 • C for 20 min and then purified by RNA Clean and Concentrator-5 Kit (Zymo Research). RNA was used for the assessment of sequencing independent single primer amplification protocol (SISPA) with some modifications reported by Lorusso [27]. Libraries were prepared by using Nextera DNA Flex Library Prep (Illumina Inc., San Diego, CA) according to the manufacturer's protocol. ...
Article
Full-text available
Introduction: Here we reported the virological, entomological and epidemiological characteristics of the large autochthonous outbreak of dengue (DENV) occurred in a small village of the Lombardy region (Northern Italy) during summer 2023. Methods: After the diagnosis of the first autochthonous case on August 18, 2023, public health measures, including epidemiological investigation and vector control measures, were carried out. A serological screening for DENV antibodies detection was offered to the population. In the case of positive DENV IgM, a second sample was collected to detect DENV RNA and verify seroconversion. Entomological and epidemiological investigations were also performed. A modeling analysis was conducted to estimate the dengue generation time, transmission potential, distance of transmission, and assess diagnostic delays. Results: Overall, 416 subjects participated to the screening program and 20 were identified as DENV-1 cases (15 confirmed and 5 probable). In addition, DENV-1 infection was diagnosed in 24 symptomatic subjects referred to the local Emergency Room Department for suggestive symptoms and 1 case was identified through blood donation screening. The average generation time was estimated to be 18.3 days (95 % CI: 13.1-23.5 days). R 0 was estimated at 1.31 (95 % CI: 0.76-1.98); 90 % of transmission occurred within 500m. Entomological investigations performed in 46 pools of mosquitoes revealed the presence of only one positive pool for DENV-1. Discussion: This report highlights the importance of synergic surveillance, including virological, entomological and public health measures to control the spread of arboviral infections.
... The RT-PCR amplification products were sequenced using Sanger sequencing. Finally, the whole-genome sequence of the pool was derived using the metagenomic approach described in Lorusso et al. [11] ( Table 1). ...
Article
Full-text available
The dengue virus (DENV) is a mosquito-borne flavivirus endemic to many tropical and subtropical regions. Over the past few decades, the global incidence of dengue has risen dramatically, with the virus now present in over 100 countries, putting nearly half of the world’s population at risk. This increase is attributed to several factors, including urbanization, climate change, and global travel, which facilitate the spread of both the virus and its mosquito vectors. While dengue is primarily associated with tropical regions, outbreaks in temperate areas are becoming increasingly common due to the spread of Aedes albopictus, a competent vector for DENV that can adapt to cooler climates. This study investigates the molecular dynamics and geographic evolution of DENV type 1 (DENV-1) strains isolated from 13 patients during an autochthonous outbreak in Lombardy, Northern Italy, between August and September 2023. Additionally, Aedes albopictus mosquitoes were collected from a neighboring area to assess their potential role in the outbreak. A metagenomic approach was used to recover DENV-1 consensus sequences from clinical samples. Genotype classification and phylogenetic analyses were performed using Bayesian methods and a comprehensive dataset of DENV-1 sequences from other countries. The Italian autochthonous strains clustered with South American strains collected between 2020 and 2023, specifically those belonging to genotype V, subtype D. Bayesian analysis estimated a mean evolutionary substitution rate of 8.234 × 10−⁴ substitutions per site per year (95% HPD interval: 7.1448 × 10−⁴–9.3343 × 10−⁴), with the time to the most recent common ancestor (tMRCA) dating back to 1972 (95% HPD interval: 1968–1976). These findings suggest the likely introduction of the virus into the region from endemic areas in South America, followed by local transmission. This study offers valuable insights into the dynamics of the DENV-1 outbreak in Lombardy, underscoring the importance of genomic surveillance in monitoring viral spread and evolution. The findings emphasize the critical need for enhanced molecular and entomological surveillance to detect and respond to emerging autochthonous DENV cases in temperate regions where competent vectors, such as Aedes albopictus, are present. Public health strategies should prioritize integrated vector management, real-time genomic monitoring, and awareness campaigns to mitigate the risk of future outbreaks. These measures are essential to address the growing threat posed by the geographic expansion of the dengue virus.
... In addition, it was hypothesized that the presence of salivary enzymes [13,14], proteins [9,15], cellular debris [16] and high bacterial loads in oral fluids as well as inadequate transport conditions [17] can contribute to further degradation of viral RNA. To avoid degradation of intact virus or viral nucleic acids, different stabilizers have been described for the molecular detection of PRRSV [18], avian influenza virus and Newcastle Disease virus [19], SARS-CoV-2 [20], herpes simplex viruses, enteroviruses, and adenoviruses [21]. However, the stability of swIAV in aggregated samples is poorly investigated. ...
Article
Full-text available
Background Aggregated samples such as oral fluids (OFs) display an animal friendly and time and cost-efficient sample type for swine Influenza A virus (swIAV) monitoring. However, further molecular and biological characterization of swIAV is of particular significance. The reportedly inferior suitability of aggregated samples for subtyping of swIAV presents a major drawback compared to nasal swabs, still considered the most appropriate sample type for this purpose (Garrido-Mantilla et al. BMC Vet Res 15(1):61, 2019). In addition, the viral load in the original sample, storage conditions and characteristics of different swIAV strains might further compromise the eligibility of aggregated samples for molecular detection and subtyping. Therefore, the present study aimed to evaluate the suitability of stabilizing media to minimize the degradation of viral RNA and thus increase the detection and subtyping rate of swIAV by RT-qPCR in spiked OFs under different conditions (virus strain, storage temperature and viral load in the original sample) over a time span of 14 days. Results The use of stabilizing media in spiked OFs resulted in a significant higher probability to detect swIAV RNA compared to OFs without stabilizers (OR = 46.1, p < 0.001). In addition, swIAV degradation over time was significantly reduced in samples suspended with stabilizer (OR = 5.80, p < 0.001), in samples stored at 4 °C (OR = 2.53, p < 0.001) and in samples spiked with the avian derived H1N2 subtype (OR = 2.26, p < 0.01). No significant differences in swIAV RNA detection and degradation of swIAV RNA in spiked OFs over time were observed between the three different stabilizing media. Conclusion Addition of stabilizers and storage of samples under cooled conditions significantly improved detection and subtyping of swIAV in spiked OFs.
... RNA was treated with TURBO DNase (Thermo Fisher Scientific, Waltham, MA) at 37 °C for 20 min and then purified by RNA Clean and Concentrator-5 Kit (Zymo Research). RNA was used for the assessment of sequencing independent single primer amplification protocol (SISPA) with some modifications reported by Lorusso [27]. Libraries were prepared by using Nextera DNA Flex Library Prep (Illumina Inc., San Diego, CA) according to the manufacturer's protocol. ...
Preprint
Full-text available
Introduction. Here we reported the virological, entomological and epidemiological characteristics of the large autochthonous outbreak of dengue (DENV) occurred in a small village of the Lombardy region (Northern Italy) during summer 2023. Methods. After the diagnosis of the first autochthonous case on 18 August 2023, public health measures, including epidemiological investigation and vector control measures, were carried out. A serological screening for DENV antibodies detection was offered to the population. In the case of positive DENV IgM, a second sample was collected to detect DENV RNA and verify seroconversion. Entomological and epidemiological investigations were also performed. A modeling analysis was conducted to estimate the dengue generation time, transmission potential, distance of transmission, and assess diagnostic delays. Results. Overall, 416 subjects participated to the screening program and 20 were identified as DENV-1 cases (15 confirmed and 5 probable). In addition, DENV-1 infection was diagnosed in 24 symptomatic subjects referred to the local Emergency Room Department for suggestive symptoms and 1 case was identified through blood donation screening. The average generation time was estimated to be 18.3 days (95% CI: 13.1-23.5 days). R0 was estimated at 1.31 (95% CI: 0.76-1.98); 90% of transmission occurred within 500m. Entomological investigations performed in 46 pools of mosquitoes revealed the presence of only one positive pool for DENV-1. Discussion. This report highlights the importance of synergic surveillance, including virological, entomological and public health measures to control the spread of arboviral infections.
Preprint
Full-text available
Background Aggregated samples such as oral fluids (OFs) display an animal friendly and time and cost-efficient sample type for swine Influenza A virus (swIAV) monitoring. However, further molecular and biological characterization of swIAV is of particular significance. The reportedly inferior suitability of aggregated samples for subtyping of swIAV presents a major drawback compared to nasal swabs, still considered the most appropriate sample type for this purpose (1). In addition, the viral load in the original sample, storage conditions and characteristics of different swIAV strains might further compromise the eligibility of aggregated samples for molecular detection and subtyping. Therefore, the present study aimed to evaluate the suitability of stabilizing media to minimize the degradation of viral RNA and thus increase the detection and subtyping rate of swIAV by RT-qPCR in spiked OFs under different conditions (virus strain, storage temperature and viral load in the original sample) over a time span of 14 days. Results The use of stabilizing media in spiked OFs resulted in a significant higher probability to detect swIAV RNA compared to OFs without stabilizers (OR = 46.1, p < 0.001). In addition, the probability of swIAV degradation over time was significantly reduced in samples suspended with stabilizer (OR = 5.80, p < 0.001), in samples stored at 4°C (OR = 2.53, p < 0.001) and in samples spiked with the avian derived H1N1 subtype (OR = 2.26, p < 0.01). No significant differences in swIAV RNA detection and degradation of swIAV RNA in spiked OFs over time were observed between the three different stabilizing media. Conclusion Addition of stabilizers and storage of samples at cooled conditions highly significantly improved detection and subtyping of swIAV in spiked OFs.
Article
Echovirus 11 (E11) has gained attention owing to its association with severe neonatal infections. Due to the limited data available, the World Health Organization (WHO) considers public health risk to the general population to be low. The present study investigated the genetic variation and molecular evolution of E11 genomes collected from May to December 2023. Whole genome sequencing (WGS) was performed for 16 E11 strains. Phylogenetic analysis on WG showed how all Italian strains belonged to genogroup D5, similarly to other E11 strains recently reported in France and Germany all together aggregated into separate clusters. A cluster‐specific recombination pattern was also identified using phylogenetic analysis of different genome regions. Echovirus 6 was identified as the major recombinant virus in 3C pro and 3D pol regions. The molecular clock analysis revealed that the recombination event probably occurred in June 2018 (95% HPD interval: Jan 2016–Jan 2020). Shannon entropy analyses, within P1 region, showed how 11 amino acids exhibited relatively high entropy. Five of them were exposed on the canyon region which is responsible for receptor binding with the neonatal Fc receptor. The present study showed the recombinant origin of a new lineage of E11 associated with severe neonatal infections.
Article
Full-text available
The SARS-CoV-2 epidemic started in late December 2019 in Wuhan, China, and has since impacted a large portion of China and raised major global concern. Herein, we investigated the extent of molecular divergence between SARS-CoV-2 and other related coronaviruses. Although we found only 4% variability in genomic nucleotides between SARS-CoV-2 and a bat SARS-related coronavirus (SARSr-CoV; RaTG13), the difference at neutral sites was 17%, suggesting the divergence between the two viruses is much larger than previously estimated. Our results suggest that the development of new variations in functional sites in the receptor-binding domain (RBD) of the spike seen in SARS-CoV-2 and viruses from pangolin SARSr-CoVs are likely caused by natural selection besides recombination. Population genetic analyses of 103 SARS-CoV-2 genomes indicated that these viruses had two major lineages (designated L and S), that are well defined by two different SNPs that show nearly complete linkage across the viral strains sequenced to date. We found that L lineage was more prevalent than the S lineage within the limited patient samples we examined. The implication of these evolutionary changes on disease etiology remains unclear. These findings strongly underscores the urgent need for further comprehensive studies that combine viral genomic data, with epidemiological studies of coronavirus disease 2019 (COVID-19).
Article
Full-text available
The ongoing outbreak of viral pneumonia in China and across the world is associated with a new coronavirus, SARS-CoV-2. This outbreak has been tentatively associated with a seafood market in Wuhan, China, where the sale of wild animals may be the source of zoonotic infection. Although bats are probable reservoir hosts for SARS-CoV-2, the identity of any intermediate host that may have facilitated transfer to humans is unknown. Here we report the identifcation of SARS-CoV-2-related coronaviruses in Malayan pangolins (Manis javanica) seized in anti-smuggling operations in southern China. Metagenomic sequencing identifed pangolin-associated coronaviruses that belong to two sub-lineages of SARS-CoV-2-related coronaviruses, including one that exhibits strong similarity in the receptor-binding domain to SARS-CoV-2. The discovery of multiple lineages of pangolin coronavirus and their similarity to SARS-CoV-2 suggests that pangolins should be considered as possible hosts in the emergence of new coronaviruses and should be removed from wet markets to prevent zoonotic transmission.
Article
Full-text available
The recent epidemics caused by the novel human coronavirus 2019 (2019-nCoV), now referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is having a great impact not only on the Chinese health care system and economy but mainly on the global perception of the risk and on the change of common habits and life styles. The novel coronavirus (CoV) recognises, with high probability, a zoonotic origin but the role of animals in the SARS-CoV-2 epidemiology is still largely unknown. However, CoVs have been known in animals since several decades, so that veterinary coronavirologists have a great expertise on how to face CoV infections in animals, which could represent a model for SARS-CoV-2 infection in humans. In the present paper, we provide an up-to-date review of the literature currently available on animal CoVs, focusing on the molecular mechanisms that are responsible for the emergence of novel CoV strains with different antigenic, biologic and/or pathogenetic features. A full comprehension of the mechanisms driving the evolution of animal CoVs will help better understand the emergence, spreading, and evolution of SARS-CoV-2.
Article
Full-text available
Alternative hosts and model animals The severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) pandemic may have originated in bats, but how it made its way into humans is unknown. Because of its zoonotic origins, SARS-CoV-2 is unlikely to exclusively infect humans, so it would be valuable to have an animal model for drug and vaccine development. Shi et al. tested ferrets, as well as livestock and companion animals of humans, for their susceptibility to SARS-CoV-2 (see the Perspective by Lakdawala and Menachery). The authors found that SARS-CoV-2 infects the upper respiratory tracts of ferrets but is poorly transmissible between individuals. In cats, the virus replicated in the nose and throat and caused inflammatory pathology deeper in the respiratory tract, and airborne transmission did occur between pairs of cats. Dogs appeared not to support viral replication well and had low susceptibility to the virus, and pigs, chickens, and ducks were not susceptible to SARS-CoV-2. Science , this issue p. 1016 ; see also p. 942
Preprint
Full-text available
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the infectious disease COVID-19, which was first reported in Wuhan, China in December, 2019. Despite the tremendous efforts to control the disease, COVID-19 has now spread to over 100 countries and caused a global pandemic. SARS-CoV-2 is thought to have originated in bats; however, the intermediate animal sources of the virus are completely unknown. Here, we investigated the susceptibility of ferrets and animals in close contact with humans to SARS-CoV-2. We found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but efficiently in ferrets and cats. We found that the virus transmits in cats via respiratory droplets. Our study provides important insights into the animal reservoirs of SARS-CoV-2 and animal management for COVID-19 control.
Article
Full-text available
The ongoing outbreak of viral pneumonia in China and beyond is associated with a novel coronavirus, SARS-CoV-2¹. This outbreak has been tentatively associated with a seafood market in Wuhan, China, where the sale of wild animals may be the source of zoonotic infection². Although bats are likely reservoir hosts for SARS-CoV-2, the identity of any intermediate host that might have facilitated transfer to humans is unknown. Here, we report the identification of SARS-CoV-2-related coronaviruses in Malayan pangolins (Manis javanica) seized in anti-smuggling operations in southern China. Metagenomic sequencing identified pangolin-associated coronaviruses that belong to two sub-lineages of SARS-CoV-2-related coronaviruses, including one that exhibits strong similarity to SARS-CoV-2 in the receptor-binding domain. The discovery of multiple lineages of pangolin coronavirus and their similarity to SARS-CoV-2 suggests that pangolins should be considered as possible hosts in the emergence of novel coronaviruses and should be removed from wet markets to prevent zoonotic transmission.
Article
The emerging global infectious COVID-19 disease by novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) presents critical threats to global public health and the economy since it was identified in late December 2019 in China. The virus has gone through various pathways of evolution. To understand the evolution and transmission of SARS-CoV-2, genotyping of virus isolates is of great importance. This study presents an accurate method for effectively genotyping SARS-CoV-2 viruses using complete genomes. The method employs the multiple sequence alignments of the genome isolates with the SARS-CoV-2 reference genome. The single-nucleotide polymorphism (SNP) genotypes are then measured by Jaccard distances to track the relationship of virus isolates. The genotyping analysis of SARS-CoV-2 isolates from the globe reveals that specific multiple mutations are the predominated mutation type during the current epidemic. The proposed method serves an effective tool for monitoring and tracking the epidemic of pathogenic viruses in their global and local genetic variations. The genotyping analysis shows that the genes encoding the S proteins and RNA polymerase, RNA primase, and nucleoprotein, undergo frequent mutations. These mutations are critical for vaccine development in disease control.